Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Erika Peereboom

Physician Assistant Rockaway, NJ Physician Assistant

NPI 1023146537 CMS profile 10899687

35 Green Pond Rd, Rockaway, NJ 07866

Open in the dashboard

General payments

$7,699

491 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Erika Peereboom of Rockaway, NJ is reported in the CMS Open Payments database as having received $7,699 across 491 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,630 113
2024 General $1,771 101
2023 General $1,567 111
2022 General $1,808 98
2021 General $923 68

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erika Peereboom
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Erika Peereboom were reported at $1,630. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Erika Peereboom Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $923 $132 $37–$438 $132
2022 $1,808 $155 $48–$522 $149
2023 $1,567 $167 $52–$557 $160
2024 $1,771 $178 $55–$600 $164
2025 $1,630 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Amgen Inc. $948 68 payments
  2. Sun Pharmaceutical Industries Inc. $873 55 payments
  3. AbbVie, Inc. $780 71 payments
  4. Ortho Dermatologics, a division of Bausch Health US, LLC $651 44 payments
  5. Genzyme Corporation $610 28 payments
  6. Medimetriks Pharmaceuticals, Inc. $557 3 payments
  7. Galderma Laboratories, L.P. $529 36 payments
  8. Regeneron Healthcare Solutions, Inc. $498 27 payments
  9. Incyte Corporation $359 23 payments
  10. Mayne Pharma Inc. $337 30 payments
  11. Other $1,558 106 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,850 482 payments
  2. Consulting Fee $500 2 payments
  3. Education $349 7 payments
Products named General payments · program years 2021–2025
  1. Otezla $948 68 payments
  2. DUPIXENT Immunology $825 40 payments
  3. JUBLIA $611 41 payments
  4. ILUMYA $543 42 payments
  5. Neo-Synalar $500 2 payments
  6. ARAZLO $409 28 payments
  7. SKYRIZI $401 34 payments
  8. DUOBRII $399 28 payments
  9. DUPIXENT Inflammation And Immunology $393 21 payments
  10. OPZELURA $359 23 payments
  11. Other $4,337 275 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

491 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record